Do not let to be late: Overview of reasons for melanoma delayed diagnosis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 3873-3877

  Gajda, Maksymilian ^a   Kaminska Winciorek, Grazyna ^b  

^a Clinical Oncology Ward Starkiewicz Specialised Hospital   (Poland)

^b Center for Diagnostics and Treatment of Skin Diseases   (Poland)

Author keywords

Cutaneous melanoma; Delayed diagnosis; Melanoma awareness; Melanoma prevention

Indexed keywords

ADVERSE EFFECTS; ATTITUDE TO HEALTH; DELAYED DIAGNOSIS; FEMALE; HUMAN; MALE; MELANOMA; PATHOLOGY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGY; RISK FACTOR; SKIN; SKIN NEOPLASMS; SUNBURN; SUNLIGHT; SURVIVAL RATE; ULTRAVIOLET RADIATION;

DELAYED DIAGNOSIS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MELANOMA; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RISK FACTORS; SKIN; SKIN NEOPLASMS; SUNBURN; SUNLIGHT; SURVIVAL RATE; ULTRAVIOLET RAYS;

EID: 84902675146     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.3873     Document Type: Short Survey

References (37)

1. Al-Naggar RA, Al-Naggar TH, Bobryshev YV (2011). Perceptions and opinions towards skin cancer prevention in Malaysia: A Qualitative approach. Asian Pac Cancer Prev, 12, 995-9.
2. Alexandrescu DT (2009). Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J, 15, 1.
3. American Cancer Society (2013). Cancer Facts&Figures 2013. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf, accessed on 23.11.2013.
4. Andsoy II, Gul A, Sahin AO, Karabacak H (2013). What turkish nurses know and do about skin cancer and sun protective behavior. Asian Pac J Cancer Prev, 14, 7663-8.
5. Baade PD, English DR, Youl PH et al (2006). The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol, 142, 1422-7.
6. Balch CM, Gershenwald JE, Soong SJ, et al (2009). Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol, 27, 6199-206.
7. Betti R, Vergani R, Tolomio E, Santambrogio R, Crosti C (2003). Factors of delay in the diagnosis of melanoma. Eur J Dermatol, 13, 183-8.
8. Byrd KM, Wilson DC, Hoyler SS, Peck GL (2004). Advanced presentation of melanoma in African Americans. J Am Acad Dermatol, 50, 21-4.
9. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 12.04.2014.
10. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC (2012). Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol, 167, 1124-30.
11. Giacomel J, Zalaudek I, Mordente I, Nicolino R, Argenziano G (2008). Never perform laser treatment of skin tumors with clinical "EFG" criteria. J Dtsch Dermatol Ges, 6, 386-8.
12. Grann AF, Froslev T, Olesen AB, Schmidt H, Lash TL (2013). The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study. Br J Cancer, 109, 265-71.
13. Houghton AN, Polsky D (2002). Focus on melanoma. Cancer Cell, 2, 275-8.
14. Hu S, Soza-Vento RM, Parker DF, Kirsner RS (2006). Comparison of stage at diagnosis of melanoma among hispanic, black, and white patients in miami-dade county, Florida. Arch Dermatol, 142, 704-8.
15. Kang JC, Wanek LA, Essner R, et al (2005). Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol, 23, 4764-70.
16. Karabeg R, Lukic D, Janjic Z, et al (2012). The analysis of reasons for malignant skin tumors late diagnosis. Mater Sociomed, 24, 73-5.
17. Krige JE, Isaacs S, Hudson DA, et al (1991). Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer, 68, 2064-8.
18. Kycler W, Grodecka-Gazdecka S, Breborowicz J, Filas V, Teresiak M (2002). Prognostic value of selected immunohistochemical markers in skin melanoma. Nowotwory, 6, 487-95.
19. Lee HY, Chay WY, Tang MB, Chio MT, Tan SH (2012). Melanoma: differences between Asian and Caucasian patients. Ann Acad Med Singapore, 41, 17-20.
20. Liang JJ, Robinson E, Martin RC (2010). Cutaneous melanoma in New Zealand: 2000-2004. ANZ J Surg, 80, 312-6.
21. Lin JS, Eder M, Weinmann S (2011). Behavioral counseling to prevent skin cancer: asystematic review for the U.S. preventive services task force. Ann Intern Med, 154, 190-201.
22. Malak AT, Yildirim P, Yildiz Z, Bektas M (2013). Effects of training about skin cancer on farmers' knowledge level and attitudes. Asian Pac J Cancer Prev, 12, 117-20.
23. Matzke TJ, Andrew K, Bean AK, Ackerman T (2009). Avoiding delayed diagnosis of malignant melanoma. J Nurse Pract, 5, 42-6.
24. McLaughlin JM, Fisher JL, Paskett ED (2011). Marital status and stage at diagnosis of cutaneous melanoma: results from the surveillance epidemiology and end results (SEER) program, 1973-2006. Cancer, 117, 1984-93.
25. Pipitone M, Robinson JK, Camara C, Chittineni B, Fisher SG (2002). Skin cancer awareness in suburban employees: a Hispanic perspective. J Am Acad Dermatol, 47, 118-23.
26. Reed KB, Brewer JD, Lohse CM, et al (2012). Increasing incidence of melanoma among young adults: an epidemiological study in olmsted county, minnesota. Mayo Clin Proc, 87, 328-34.
27. Richard MA, Grob JJ, Avril MF, et al (2000b): Delays in diagnosis and melanoma prognosis: the role of patients. Int J Cancer, 89, 271-9.
28. Richard MA, Grob JJ, Avril MF, et al (2000a). Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer, 89, 280-5.
29. Rigel DS, Friedman RJ, Kopf AW, Polsky D (2005). ABCDE -an evolving concept in the early detection of melanoma. Arch Dermatol, 141, 1032-4.
30. Saraiya M, Hall HI, Thompson T, et al (2004). Skin cancer screening among U.S. adults from 1992, 1998, and 2000 national health interview surveys. Prev Med, 39, 308-14.
31. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M (2002). Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res, 12, 389-94.
32. Smith T (1979). The Queensland Melanoma Project--an exercise in health education. Br Med J, 1, 253-4.
33. Szczurkowska P, Ornowska M, Sobjanek M, et al (2012). Cutaneous melanoma - clinicopathological analysis of 128 patients from Northern Polish population. Clin Dermatol, 14, 122-6.
34. Szkultecka-Debek M, Lugowska I, Sozanska-Solak A, et al (2012). Stage III/IV melanoma in Poland: epidemiology, standard of care and treatment related costs. JPHOR, 2, 41-7.
35. Temoshok L, DiClemente RJ, Sweet DM, Blois MS, Sagebiel RW (1984). Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer, 54, 3048-53.
36. The Centers for Disease Control and Prevention. CDC 24/7: Saving life. Protecting people. (2012). Skin Cancer. Skin Cancer Rates by Race and Ethnicity. Available from: http://www.cdc.gov/cancer/skin/statistics/race.htm, accessed on 14.04.2014.
37. Zalaudek I, Argenziano G, Soyer HP, et al (2006). Dermoscopy Working Group. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol, 154, 431-7.